News

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new ...
The American Journal of Managed Care2d
Ruxolitinib Cream and Atopic Dermatitis at AAD 2025
A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...
Medical Marketing & Media1d
Galderma wants to help patients get over their itch in Nemluvio DTC push
On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of ...
The American Journal of Managed Care8h
Chronic Hand Eczema Has Significant Impacts on Patients' Lives, Survey Reveals
Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.
Morningstar2d
Revolutionizing Atopic Dermatitis 2025 heads to Nashville, delivering cutting-edge insights for dermatology professionals
The Revolutionizing Atopic Dermatitis (RAD) Conference 2025 takes place June 6–7 at the DoubleTree by Hilton Hotel Nashville Downtown, offering cutting-edge updates on the treatment and ...
Sportschosun on MSN16h
Atopy, rhinitis, asthma, common causes found...Allergic Cues Discovered miR4497
A research team at Korea University Medical School discovered a gene-regulating substance called 'miR-4497', which was ...
Healio5d
FDA approved dupilumab for treatment of chronic spontaneous urticaria
The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...
manilatimes2d
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
Atopic dermatitis (AD) is the most common form of eczema ... there remains a significant unmet need and opportunity to improve treatment options for millions of patients. This press release contains ...